§ EQUITY
USD

CLYM

CLIMB BIO INC
USD
LAST
n/a
n/aPREV CLOSE · n/a
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX

§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY

§ 05 · WHO OWNS IT
Top institutional holders
All holders →
FundShares% portΔ Q/Q
RA CAPITAL MANAGEMENT, L.P.8.8M0.6%+0%
MPM BIOIMPACT LLC2.6M1.4%−3%
RA CAPITAL MANAGEMENT, L.P.2.5M0.2%n/a
BRAIDWELL LP1.5M0.3%n/a
GREAT POINT PARTNERS LLC1.3M2.1%+36%
Point721.3M0.0%+331%
AC INTELLIGENCE

Top institutional owners for CLYM as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.

§ 06 · WHO OWNS IT · BY STRATEGY

OTHER86.3% · 53 holders
TACTICAL / MACRO5.0% · 4 holders
SYSTEMATIC / QUANT3.1% · 3 holders
DEALER / BANK2.6% · 12 holders
PASSIVE / INDEX2.2% · 4 holders
INCOME / DEFENSIVE0.5% · 1 holder
QUALITY / COMPOUNDER0.4% · 4 holders
AC INTELLIGENCE

Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.

§ 07 · INSIDER ACTIVITY · LAST 180 DAYS

NO INSIDER FILINGS
AC INTELLIGENCE

No Form 4 filings on record for CLYM in the last 180 days.

§ 08 · COVERAGE · OUR RECENT NOTES

No notes mention CLYM yet.